Interaction Checker

Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more

Three cancer drugs have been added to the interaction checker

Monday 11 February 2019

Lapatinib, neratinib and rucaparib are now listed in the interaction checker as cancer drugs and interactions can be found with all the comedications.

  • Lapatinib (Tykerb®, Tyverb®) is a HER2 inhibitor and is indicated for the treatment of breast cancer
  • Neratinib (Nerlynx®) is a HER1/2/3 inhibitor and is indicated for the treatment of breast cancer
  • Rucaparib (Rubraca®) is a PARP inhibitor and is indicated for the treatment of epithelial ovarian, fallopian tube and primary peritoneal cancer
ENDORSED BY
Bopa Esop gro%c3%9f %28resized%29